UBS Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3K Buy
+2,213
New +$14.3K ﹤0.01% 7343
2024
Q3
Sell
-1,557
Closed -$10.1K 9208
2024
Q2
$10.1K Sell
1,557
-538
-26% -$3.48K ﹤0.01% 6556
2024
Q1
$13.6K Buy
+2,095
New +$13.6K ﹤0.01% 5924
2023
Q4
Sell
-9,095
Closed -$58.8K 9270
2023
Q3
$58.8K Hold
9,095
﹤0.01% 5070
2023
Q2
$58.8K Buy
+9,095
New +$58.8K ﹤0.01% 5322
2022
Q4
Sell
-2,095
Closed -$14K 10671
2022
Q3
$14K Sell
2,095
-7,000
-77% -$46.8K ﹤0.01% 6901
2022
Q2
$59K Buy
+9,095
New +$59K ﹤0.01% 4787
2022
Q1
Sell
-9,095
Closed -$59K 10302
2021
Q4
$59K Hold
9,095
﹤0.01% 5669
2021
Q3
$59K Hold
9,095
﹤0.01% 5117
2021
Q2
$59K Hold
9,095
﹤0.01% 5243
2021
Q1
$0 Hold
9,095
﹤0.01% 8678
2020
Q4
$58K Hold
9,095
﹤0.01% 5081
2020
Q3
$59K Hold
9,095
﹤0.01% 4684
2020
Q2
$59K Buy
9,095
+538
+6% +$3.49K ﹤0.01% 4897
2020
Q1
$55K Hold
8,557
﹤0.01% 4887
2019
Q4
$55K Buy
8,557
+2,000
+31% +$12.9K ﹤0.01% 5260
2019
Q3
$0 Hold
6,557
﹤0.01% 7486
2019
Q2
$0 Hold
6,557
﹤0.01% 7481
2019
Q1
$42K Buy
6,557
+1,531
+30% +$9.81K ﹤0.01% 4883
2018
Q4
$35K Hold
5,026
﹤0.01% 5470
2018
Q3
$38K Sell
5,026
-631
-11% -$4.77K ﹤0.01% 5486
2018
Q2
$42K Sell
5,657
-1,959
-26% -$14.5K ﹤0.01% 5234
2018
Q1
$66K Buy
+7,616
New +$66K ﹤0.01% 4676
2017
Q4
Sell
-2,048
Closed -$14K 7336
2017
Q3
$14K Buy
2,048
+1,048
+105% +$7.16K ﹤0.01% 5814
2017
Q2
$7K Hold
1,000
﹤0.01% 6075
2017
Q1
$6K Sell
1,000
-786
-44% -$4.72K ﹤0.01% 6031
2016
Q4
$11K Buy
1,786
+786
+79% +$4.84K ﹤0.01% 5943
2016
Q3
$6K Buy
1,000
+894
+843% +$5.36K ﹤0.01% 6175
2016
Q2
$1K Buy
+106
New +$1K ﹤0.01% 6727
2016
Q1
Sell
-5,389
Closed -$31K 7324
2015
Q4
$31K Hold
5,389
﹤0.01% 5185
2015
Q3
$27K Sell
5,389
-122
-2% -$611 ﹤0.01% 5221
2015
Q2
$29K Sell
5,511
-2,115
-28% -$11.1K ﹤0.01% 5222
2015
Q1
$38K Sell
7,626
-1,239
-14% -$6.17K ﹤0.01% 4877
2014
Q4
$46K Buy
+8,865
New +$46K ﹤0.01% 4807